Spirovant Sciences Competitors and Similar CompaniesClear all
Spirovant Sciences's competitors and similar companies include Vertex Pharmaceuticals, Amneal Pharmaceuticals, Asklepios BioPharmaceutical and Cell Therapies.
 Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  Amneal Pharmaceuticals Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas. |  Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein. |  Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products. | |
Founding Date | Founding Date 2016 | Founding Date 1989 | Founding Date 2002 | Founding Date 2001 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Philadelphia, US HQ | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Chapel Hill, US HQ Roslin, GB | Locations Melbourne, AU HQ | |
Employees | Employees 234% decrease | Employees 5,40013% increase | Employees 8,1005% increase | Employees 5172% increase | Employees 733% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 121.4 b | Valuation ($) 2.6 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $12b (FY, 2025) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods $1.9b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $10.4b (FY, 2025) | Gross profit $1.1b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised $ 235m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View companyAmneal Pharmaceuticals
HQ
Bridgewater Township, US
Employees
8,100↑ 5% increase
Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas.
View companyAsklepios BioPharmaceutical
HQ
Chapel Hill, US
Employees
517↑ 2% increase
Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.
View companyCell Therapies
HQ
Melbourne, AU
Employees
73↓ 3% decrease
Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.
View company